Health Condition 1: A304- Borderline lepromatous leprosy Health Condition 2: A303- Borderline leprosy Health Condition 3: A302- Borderline tuberculoid leprosy Health Condition 4: A300- Indeterminate leprosy Health Condition 5: A305- Lepromatous leprosy Health Condition 6: A309- Leprosy, unspecified Health Condition 7: A308- Other forms of leprosy Health Condition 8: A301- Tuberculoid leprosy
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Control Intervention1: Nil: Nil
Sponsors
AIIMS Gorakhpur
Eligibility
Inclusion criteria
Inclusion criteria: 1. All the leprosy patients including new, partially treated, on treatment, and released from treatment, who visited the dermatology department were included in the study after taking informed consent irrespective of age, gender and treatment status. 2. Able to provide informed consent, able to complete questionnaires.
Exclusion criteria
Exclusion criteria: Patients with disabilities due to some other known cause
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To analyses the trends and types of Deformities in Leprosy Patients indicating their prevalence levels and grade them according to WHO grading 2007.Timepoint: This is a cross-sectional study. Information will be collected at a single point of time. When the patient gives consent and is enrolled in the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| 2. To analyse the clinico-epidemiological trends (such as advanced age, rural occupation, socioeconomic status, male sex, nerve damage, WHO & Ridley-Jopling classifications, zero skin lesions, & leprosy reactions), & various determinants like the Distribution of health seeking behaviour, 1st symptoms, Reason for delay in diagnosis in leprosy patients at our clinic & their correlation if any to the prevalence of deformities.Timepoint: This is a cross-sectional study. information will be collected at a single point of time. When the patient gives consent & is enrolled in the study.;1.To assess the post-treatment status of leprosy skin lesions, various motor & sensory sequelae in a subset of patients who have completed MBMDT treatment.Timepoint: This is a cross-sectional study. information will be collected at a single point of time. When the patient gives consent & is enrolled in the study. | — |
Countries
India
Contacts
Public ContactDr Sriramanan Anandbabu
AIIMS Gorakhpur
Outcome results
None listed